Literature DB >> 25518058

Clinical predictors of colectomy in patients with ulcerative colitis: systematic review and meta-analysis of cohort studies.

Cláudia Camila Dias, Pedro Pereira Rodrigues, Altamiro da Costa-Pereira, Fernando Magro.   

Abstract

INTRODUCTION: Colectomy is a major event that may significantly affect the outcome of ulcerative colitis (UC) in terms of both quality of life and mortality. This paper aims to identify clinical prognostic factors that may be significantly associated with this event.
METHODS: PubMed, ISI Web of Knowledge and Scopus were searched to identify studies investigating the association between clinical factors in adult patients with UC and studied events.The clinical factors evaluated in this meta-analysis were gender, smoking habits, disease extent,use of corticosteroids, and episodes of hospitalization.
RESULTS: Of the 3753 initially selected papers, 20 were included. The analysis showed a significantly lower risk of colectomy for female patients (odds ratio [OR] 0.78 [95% CI 0.68, 0.90]) and for smoking patients (OR 0.55 [0.33, 0.91]), and a higher risk for patients with extensive disease (OR 3.68 [2.39,5.69]), for patients who took corticosteroids at least once (OR 2.10 [1.05, 4.22]), and for patients who were hospitalized (OR 4.13 [3.23, 5.27]).
CONCLUSION: Gender, smoking habits, disease extent, need for corticosteroids, and hospitalization were all significantly associated with UC prognosis. These results may clarify the relative influences of these and other prognostic factors in the natural course of the disease and therefore help improve the management approach, thus improving the follow-up of patients.

Entities:  

Mesh:

Year:  2015        PMID: 25518058     DOI: 10.1093/ecco-jcc/jju016

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  16 in total

Review 1.  AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis.

Authors:  Siddharth Singh; Joseph D Feuerstein; David G Binion; William J Tremaine
Journal:  Gastroenterology       Date:  2018-12-18       Impact factor: 22.682

Review 2.  AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis.

Authors:  Cynthia W Ko; Siddharth Singh; Joseph D Feuerstein; Corinna Falck-Ytter; Yngve Falck-Ytter; Raymond K Cross
Journal:  Gastroenterology       Date:  2018-12-18       Impact factor: 22.682

3.  Associations Between the Prognostic Nutritional Index and Morbidity/Mortality During Intestinal Resection in Patients with Ulcerative Colitis.

Authors:  Teruhiro Chohno; Motoi Uchino; Hirofumi Sasaki; Toshihiro Bando; Yoshio Takesue; Hiroki Ikeuchi
Journal:  World J Surg       Date:  2018-07       Impact factor: 3.352

Review 4.  Predictive factors for a severe clinical course in ulcerative colitis: Results from population-based studies.

Authors:  Magnus Hofrenning Wanderås; Bjørn A Moum; Marte Lie Høivik; Øistein Hovde
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

5.  Oral Contraceptive Use and Risk of Ulcerative Colitis Progression: A Nationwide Study.

Authors:  Hamed Khalili; Martin Neovius; Anders Ekbom; Jonas F Ludvigsson; Johan Askling; Andrew T Chan; Ola Olen
Journal:  Am J Gastroenterol       Date:  2016-10-11       Impact factor: 10.864

Review 6.  Contemporary Management of Ulcerative Colitis.

Authors:  Rohini Vanga; Millie D Long
Journal:  Curr Gastroenterol Rep       Date:  2018-03-27

Review 7.  Influence of environmental factors on the onset and course of inflammatory bowel disease.

Authors:  Amit Kumar Dutta; Ashok Chacko
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 8.  How Will Evolving Future Therapies and Strategies Change How We Position the Use of Biologics in Moderate to Severely Active Inflammatory Bowel Disease.

Authors:  Parambir S Dulai; Siddharth Singh; Niels V Casteele; Brigid S Boland; William J Sandborn
Journal:  Inflamm Bowel Dis       Date:  2016-04       Impact factor: 5.325

9.  Long-term follow-up of patients treated with aminosalicylates for ulcerative colitis: Predictive factors of response: An observational case-control study.

Authors:  David Marti-Aguado; María Pilar Ballester; Joan Tosca; Marta Maia Bosca-Watts; Pablo Navarro; Rosario Anton; Isabel Pascual; Francisco Mora; Miguel Minguez
Journal:  United European Gastroenterol J       Date:  2019-05-29       Impact factor: 4.623

10.  Histological Inflammation in the Endoscopically Uninflamed Mucosa is Associated With Worse Outcomes in Limited Ulcerative Colitis.

Authors:  Catarina Geraldes de Frias Gomes; Alexandra Sofia Ribeiro de Almeida; Catarina Callé Lucas Mendes; Pierre Ellul; Johan Burisch; Tiffany Buhagiar; Abigail Attard; Bobby Lo; Ryan C Ungaro; Bárbara Tonilhas da Silva Morão; Catarina Ferreira Gouveia; Joana Milheiro Delgado de Carvalho E Branco; Jaime Manuel Martins Pereira Rodrigues; Cristina Teixeira; Maria Francisca Faria Dias de Castro; Gonçalo Filipe Domingos Nunes; Mariana Brito; Marília Cristina de Sousa Antunes; Paula Maria Ferreira Brinca Borralho Nunes; Joana Maria Tinoco da Silva Torres
Journal:  Inflamm Bowel Dis       Date:  2022-03-02       Impact factor: 7.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.